# Osteosarcoma Maintenance Therapy With OST31-164

Source: https://onco.cc/trials/nct04974008/  
OnCo record `nct04974008` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of OST31-164 in advanced solid tumours, run by Emerald Clinical Inc., active and no longer recruiting.

## Summary

Osteosarcoma Maintenance Therapy With OST31-164 is a phase 2 interventional study registered as NCT04974008 by Emerald Clinical Inc., with 39 participants enrolled, started 2021-10-21 and due to reach its primary completion in 2023-09-21. Interventions recorded: OST31-164.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04974008
- Phase: 2
- Setting: An Open-Label Phase 2 Study of Maintenance Therapy With OST31-164 After Resection of Recurrent Osteosarcoma
- Sponsor: Emerald Clinical Inc.
- Enrolled: 39

## Sources

- ClinicalTrials.gov NCT04974008: https://clinicaltrials.gov/study/NCT04974008

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct04974008.json